Test Price
1,200 AED✅ Home Collection Available
Comprehensive Newborn Screening Panel in UAE | 1200 AED | DHA-Licensed Laboratory
Executive Summary & Core Metrics
The Comprehensive Newborn Screening Panel is a state-of-the-art diagnostic assay designed to detect over 50 inborn errors of metabolism (IEMs) from a single heel-prick blood sample collected on filter paper — enabling life-saving early intervention within the critical neonatal window. This panel is processed under ISO 9001:2015 certification (Certificate No. INT/EGQ/2509DA/3139) and DHA Facility License No. 1143, ensuring 99.9% diagnostic sensitivity via Tandem Mass Spectrometry, Fluoroimmunoassay, and Capillary Electrophoresis.
- ●Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Processing.
- ●Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — available daily 8 AM to 11 PM.
- ●Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified specialists.
- ●Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Comprehensive Newborn Screening Panel utilizes three complementary analytical platforms — Tandem Mass Spectrometry (TMS) for amino acid and acylcarnitine profiling, Fluoroimmunoassay (FEIA) for hormone and enzyme markers, and Capillary Electrophoresis for hemoglobin variant detection. This multi-platform approach ensures detection of over 50 inherited metabolic conditions including phenylketonuria (PKU), maple syrup urine disease (MSUD), congenital hypothyroidism, congenital adrenal hyperplasia (CAH), galactosemia, and fatty acid oxidation disorders.
Pre-Test Requirements & Sample Logistics
- Sample Type: One drop of heel-prick capillary blood applied to each of 3 designated spots on filter paper (provided by DNA Labs UAE).
- Transport: Ship refrigerated at 2–8°C. DO NOT FREEZE. Freezing causes hemolysis and invalidates results.
- Documentation: Complete clinical details and comprehensive drug/supplement history must accompany the sample. Any unreported medications, herbal supplements, or maternal medications (if breastfeeding) must be disclosed.
- Collection Schedule: Samples accepted Monday, Wednesday, and Friday by 9 AM. Report delivered the next day.
- Home Collection: VIP Mobile Phlebotomy available 8 AM – 11 PM daily. Cold-chain transport maintained throughout.
| Feature | Our Test — Comprehensive Panel | Closest Alternative — Basic Screening |
|---|---|---|
| Precision & Methodology | Tandem Mass Spectrometry (TMS) + Fluoroimmunoassay (FEIA) + Capillary Electrophoresis — ultra-high sensitivity | Fluorometric or colorimetric methods only — limited analyte detection |
| Conditions Detected | 50+ IEMs including PKU, MSUD, congenital hypothyroidism, CAH, galactosemia, and fatty acid oxidation disorders | 5–10 core conditions only |
| Turnaround Time | Next-day reporting (Sample Mon/Wed/Fri by 9 AM) | 3–7 business days |
| Regulatory Compliance | DHA-Licensed • ISO 9001:2015 • UAE PDPL & ICT Health Data Laws Compliant | Variable; may lack UAE-specific accreditation |
Physician Insight & Safety Protocols
As a Consultant Medical Genetics with extensive experience in the UAE healthcare system, I want parents to understand that newborn screening is one of the most impactful preventive tools we have — these tests can identify treatable metabolic conditions days before symptoms ever appear. Every screening result, whether normal or flagged, must be clinically correlated with your baby's feeding patterns, weight gain, and overall examination findings by your pediatrician. Please remember that this panel is a screening tool, not a definitive diagnosis, and any abnormal result will be followed by confirmatory testing and specialist consultation at no delay.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Pre-Test Medication Advisory
⚠ Do not discontinue any prescribed medication or supplement administered to your newborn without consulting your attending neonatologist or pediatrician. Clinical details and complete drug history must accompany the screening sample to ensure accurate interpretation. Maternal medications (if breastfeeding) must also be reported.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do Not Collect)
- Infant has received a blood transfusion within 48 hours prior to screening — may invalidate metabolic analyte levels.
- Infant is currently on Total Parenteral Nutrition (TPN) — exogenous amino acids interfere with TMS interpretation.
- Insufficient blood volume — all three spots on the filter paper must be fully saturated with free-flowing heel-prick blood.
- Sample frozen during transport — must be shipped refrigerated; freezing lyses red blood cells and degrades analytes.
ER Red Flags — Seek Immediate Medical Attention
- Newborn exhibits persistent lethargy, poor feeding, or projectile vomiting — possible metabolic crisis.
- Unexplained seizures, hypotonia (floppy baby), or high-pitched crying in the neonatal period.
- Signs of acute metabolic decompensation: tachypnea, hypothermia, or altered consciousness.
- Abnormal newborn screening result reported — contact your neonatologist immediately for urgent confirmatory testing and metabolic consult.
Patient FAQ & Clinical Guidance
1. What conditions does the Comprehensive Newborn Screening Panel detect, and why is early detection critical?
This panel detects over 50 inborn errors of metabolism including phenylketonuria (PKU), maple syrup urine disease (MSUD), congenital hypothyroidism, congenital adrenal hyperplasia (CAH), galactosemia, and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency — conditions where early dietary or hormonal intervention can prevent irreversible neurological damage and save lives.
2. How is the blood sample collected from my newborn, and is it painful?
A rapid heel-prick collects a few drops of capillary blood onto specialized filter paper — the procedure is minimally invasive, completed in under 60 seconds, and causes only momentary discomfort comparable to a quick pinprick.
3. When will I receive the results, and who interprets them for clinical decision-making?
Results are delivered the next day when samples are collected on Monday, Wednesday, or Friday by 9 AM, and interpretation is provided by a DHA-licensed Consultant Medical Genetics with telephonic clinical guidance included for all patients.
UAE Regulatory & Data Privacy Adherence
Data Protection & Healthcare IT Compliance: This laboratory operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All patient data is encrypted, access-controlled, and processed exclusively within UAE jurisdiction.
ISO Accreditation: ISO 9001:2015 Certified (Certificate No. INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Comprehensive Newborn Screening Panel |
| Price (AED) | 1200 |
| Turnaround Time | Next day (samples Mon/Wed/Fri by 9 AM) |
| Sample Type / Matrix | Heel-prick capillary blood on filter paper (3 saturated spots) |
| Methodology Used | Tandem Mass Spectrometry (TMS) + Fluoroimmunoassay (FEIA) + Capillary Electrophoresis |
| ICD-10-CM Code | Z13.21 (Encounter for screening for inborn errors of metabolism) |
| LOINC Code | 57732-8 (Newborn screen panel by tandem mass spectrometry) |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
Medical Disclaimer: This newborn screening panel is a screening, not a diagnostic confirmation. Abnormal results require confirmatory testing and clinical correlation by a licensed physician. Do not delay seeking emergency care based on screening timelines. For appointments, insurance verification, or clinical inquiries, contact us via WhatsApp: +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians